Soleno Therapeutics Insider Sold Shares Worth $1,013,627, According to a Recent SEC Filing

Important legal information about the email you will be sending. By using this service, you agree to input your real email address and only send it to people you know. It is a violation of law in some jurisdictions to falsely identify yourself in an email. All information you provide will be used by Fidelity solely for the purpose of sending the email on your behalf. The subject line of the email you send will be "Fidelity.com: "

Soleno Therapeutics Insider Sold Shares Worth $1,013,627, According to a Recent SEC Filing

, MT Newswires - 3:25 AM ET 4/1/2025 default

03:25 AM EDT, 04/01/2025 (MT Newswires) -- Michael F. Huang, Senior Vice President of Clinical Development, on March 27, 2025, sold 14,583 shares in Soleno Therapeutics ( SLNO ) for $1,013,627. Following the Form 4 filing with the SEC, Huang has control over a total of 36,817 common shares of the company, with 36,817 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1484565/000141588925009294/xslF345X05/form4-03312025_110347.xml

MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.